Alemtuzumab or Tocilizumab in Combination With Etoposide and Dexamethasone for the Treatment of Adult Patients With Hemophagocytic Lymphohistiocytosis
Clinical trial NCT02385110 · COMPLETED
Trial details
- NCT number
- NCT02385110
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-23
- Primary completion
- 2023-01-24
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.